Revenue: The sum of all revenue fields included for a company's operating activities.
Vertex Pharmaceuticals Incorporated (VRTX) had Revenue of $3.33B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$3.33B |
$1.10B |
|
$489.20M |
|
$2.84B |
|
$2.09B |
|
$1.25B |
|
$144.90M |
|
$1.39B |
|
$1.39B |
|
$1.10B |
|
$1.10B |
|
$1.10B |
|
$1.10B |
|
$1.25B |
|
$1.30B |
|
253.70M |
|
255.20M |
|
$4.34 |
|
$4.31 |
|
| Balance Sheet Financials | |
$12.54B |
|
$1.67B |
|
$14.88B |
|
$27.42B |
|
$3.94B |
|
-- |
|
$3.24B |
|
$7.18B |
|
$20.25B |
|
$18.75B |
|
$20.25B |
|
253.35M |
|
| Cash Flow Statement Financials | |
$2.55B |
|
$-477.70M |
|
$-965.50M |
|
$5.09B |
|
$6.15B |
|
$1.07B |
|
$336.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
85.33% |
|
37.40% |
|
37.40% |
|
-- |
|
41.75% |
|
32.99% |
|
$2.31B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.28 |
|
1.56 |
|
57.62 |
|
5.43% |
|
5.87% |
|
4.01% |
|
5.43% |
|
$79.92 |
|
$9.04 |
|
$10.01 |
|